Ameriprise Financial Inc Curis Inc Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.71 - $2.43 $7,547 - $25,830
-10,630 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$4.45 - $8.09 $33,254 - $60,456
-7,473 Reduced 41.28%
10,630 $51,000
Q3 2021

Nov 15, 2021
SELL
$6.94 - $8.85 $43,361 - $55,294
-6,248 Reduced 25.66%
18,103 $142,000
Q2 2021

Aug 16, 2021
BUY
$7.45 - $16.27 $181,414 - $396,190
24,351 New
24,351 $197,000

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $409M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email